Investigating TIL Therapy for Cancer - Iovance Biotherapeutics | Icebreaker

Sign up or Log in

Teams

System

Investigating TIL Therapy for Cancer - Iovance Biotherapeutics | Icebreaker

Investigating TIL Therapy for Cancer - Iovance Biotherapeutics

Learn about our investigational tumor infiltrating lymphocyte (TIL) therapy. View our clinical trials and pipeline.

5 members

Contact info

Link

iovance.com

Members

Nick Magallanes

•

Principal, Todd Strategy Group

•

Focus on assays, method and protocol writing, and instrumentation; method development and validation; project leadership of experimental assays within Molecular Biology. Nearly 4.5 years combined work experience in regulatory environments in industry and academia: 3 years experience in Good Manufacturing Practice (GMP) and 4.5 years experience in BSL 2 labs. Project lead experience; ran all aspects of a group of Molecular Biology assays; supervised and trained numerous analysts in industry and academia. STRENGTH AREAS – Molecular Biology (DNA & RNA methods), Wildlife Biology (specifically ornithology), Microbiology, Antibiotic resistance, Method Development and Validation, Project Management/Leadership. Professional Skills: Learner, Hard-working, Responsible, Self-directed, Leader, Task-oriented.

Allie Cailliau, MPH

•

Manager, Environment, Health & Safety

•

CFO of Cara Therapeutics

•